
Buprenorphine + Naloxone Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 0.3 mg/mL, 0.6 mg/mL, 1 mg/mL
Reference Brands: Buprenex(US)
Category: Analgesic
Buprenorphine + Naloxone Injection is available in Injection and strengths such as 0.3 mg/mL, 0.6 mg/mL, 1 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Buprenorphine + Naloxone Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Buprenorphine + Naloxone Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Buprenorphine + Naloxone injection is approved in the US and EU for opioid dependence treatment, primarily used in clinical settings. In the US, brands like Sublocade are regulated by the FDA, supported by comprehensive dossiers demonstrating safety, efficacy, and manufacturing quality. In the EU, approval by EMA involves extensive dossiers, clinical data, and pharmacovigilance commitments. Due to high abuse potential, strict prescribing regulations and monitoring are enforced in both regions. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for buprenorphine + naloxone injection, ensuring adherence to European and US standards for safe, effective opioid dependency treatment.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Dexketoprofen
Strength:
12.5 mg, 25 mg,
Form: Tablets / Oral solution
Reference Brands: Enantyum (EU), Ketesse (EU)
View DetailsCarisoprodol
Strength:
250 mg, 350 mg
Form: Tablets
Reference Brands: Soma (USA/EU), Somadril (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers